- 询价
- 上海谷研
- GOY-9733
- 进口、国产
- 2025年07月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海谷研
- 库存：
56
- 规格：
10ug
产品名称： Recombinant Human B7-H1/PD-L1
Known as Programmed Cell Death 1 Ligand 1; PD-L1; PDCD1 Ligand 1; Programmed Death Ligand 1; B7 Homolog 1; B7-H1; CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Derived from Human cells
Purity Greater than 95% as determined by reducing SDS-PAGE.
Formulation Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Trehalose, pH 7.4.
Shipping The product is shipped at ambient temperature.
Storage Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.Reconstituted protein solution can be stored at 4-7°C for 2-7 days.Aliquots of reconstituted samples are stable at < -20°C for 3 months
Reconstitution Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100 μg/ml.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Endotoxin Less than 0.1 ng/ug (1 IEU/ug) as determined by LAL test.
Background CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
Recombinant Human Programmed Cell Death 1 Ligand 1 is produced by our Mammalian expression system and the target gene encoding Phe19-Thr239 is expressed with a 6His tag at the C-terminus.
以下是公司正在热销的相关产品：
培养基原材料 特价促销 酵母提取粉
培养基原材料 特价促销 酵母提取粉
特价促销 酵母提取物
用于培养基、生物发酵的原材料 特价促销 酵母提取物
用于食品中大肠杆菌的平板计数。（GB/T 4789.38-2008） 特价促销 结晶紫中性红胆盐MUG琼脂(VRBA-MUG)
用于阪崎肠杆菌的选择性分离培养以及肠道菌的计数和鉴别(SN/T 1632.1-2005)。 特价促销 结晶紫中性红胆盐葡萄糖琼脂(VRBGA)
用于水或食品中大肠菌群平板菌落计数(GB 4789.3-2010和SN0169-92)。 特价促销 结晶紫中性红胆盐琼脂(VRBA)
BAG2 Bcl-2结合抑凋亡蛋白2抗体 特价促销
BAG3 Bcl2抑凋亡蛋白Bag3抗体 特价促销
BAG5 BCL2分子伴侣调节蛋白5抗体 特价促销
BAGE2 肿瘤/抗原2.2抗体 特价促销
BAGE3 肿瘤/抗原2.3抗体 特价促销
BAGE4 肿瘤/抗原2.4抗体 特价促销
BAI1 脑特异性血管生成抑制蛋白1抗体 特价促销
BAI2/Brain Specific Angiogenesis Inhibitor 2 脑特异性血管生成抑制蛋白2抗体 特价促销
Bak Bcl-2同源拮抗剂抗体 特价促销
Band3/CD233 红细胞阴离子交换蛋白1抗体 特价促销
Anti-TRPML3 TRPML3抗体（50 ul)
Anti-TRPML3 TRPML3抗体（0.2 ml)
Anti-TRPML3-ATTO-594 TRPML3-ATTO-594抗体（50 ul)
Anti-TRPML2 TRPML2抗体（50 ul)
Anti-TRPML2 TRPML2抗体（0.2 ml)
Recombinant Human B7-H1/PD-L1Anti-TRPML1 TRPML1抗体（50 ul)
Anti-TRPML1 TRPML1抗体（0.2 ml)
Anti-TRPM8 （extracellular) TRPM8 （胞外)抗体（50 ul)
Anti-TRPM8 （extracellular) TRPM8 （胞外)抗体（25 ul)
Anti-TRPM8 （extracellular) TRPM8 （胞外)抗体（0.2 ml)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Construction of Recombinant Human Cytomegalovirus
The use of reverse genetics to generate recombinant viruses allows the researcher to investigate the exact functional significance of particular viral genes during the virus life cycle, by means of their deletion or modification in the viral
Delivery of Recombinant Adenoviruses to Human Saphenous Vein
The human saphenous vein is the most commonly used conduit for coronary artery bypass grafting owing to its ready availability, ease of harvesting, and favorable surgical handling (1 ). However, it suffers from a progressive decline
Recombinant Genetic Libraries and Human Monoclonal Antibodies
In order to comprehensively manipulate the human proteome we require a vast repertoire of pharmacological reagents. To address these needs we have developed repertoires of synthetic antibodies by phage display, where diversified
技术资料暂无技术资料 索取技术资料
